Published in Mol Neurobiol on July 03, 2013
Statins and cancers. Contemp Oncol (Pozn) (2014) 0.93
Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis. Nanomedicine (2015) 0.86
Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway. Oncol Rep (2015) 0.83
Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets. Viruses (2014) 0.79
Effects of treatment with platinum azidothymidine and azidothymidine on telomerase activity and bcl-2 concentration in hepatocellular carcinoma- induced rats. Avicenna J Med Biotechnol (2014) 0.79
Simvastatin modulates mesenchymal stromal cell proliferation and gene expression. PLoS One (2015) 0.76
Atorvastatin regulates apoptosis in chronically ischemic myocardium. J Card Surg (2014) 0.76
Virtual pathway explorer (viPEr) and pathway enrichment analysis tool (PEANuT): creating and analyzing focus networks to identify cross-talk between molecules and pathways. BMC Genomics (2015) 0.75
Meta-analysis of studies using statins as a reducer for primary liver cancer risk. Sci Rep (2016) 0.75
RGD-conjugated mesoporous silica-encapsulated gold nanorods enhance the sensitization of triple-negative breast cancer to megavoltage radiation therapy. Int J Nanomedicine (2016) 0.75
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. Alzheimers Res Ther (2017) 0.75
Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells. Gut Liver (2016) 0.75
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science (2007) 10.60
BCL-2 family: regulators of cell death. Annu Rev Immunol (1998) 6.41
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol (2005) 5.30
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med (2001) 3.69
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia (2002) 2.89
Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells. Am J Gastroenterol (2008) 2.03
BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ (2006) 1.97
Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol (1999) 1.83
Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab (2002) 1.47
Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL. Cardiovasc Drugs Ther (2012) 1.46
The role of statins in cancer therapy. Oncologist (2006) 1.46
Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol (2004) 1.40
NF- kappa B2/p100 induces Bcl-2 expression. Leukemia (2003) 1.39
Bcl-2 family regulation of neuronal development and neurodegeneration. Biochim Biophys Acta (2004) 1.36
3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Atherosclerosis (2002) 1.31
Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol (2002) 1.30
Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes. Free Radic Biol Med (2011) 1.24
Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer (2008) 1.19
Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem (2007) 1.16
Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther (2004) 1.16
Cell biology. Cellular demolition and the rules of engagement. Science (2007) 1.13
Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression. Int J Oncol (2011) 1.10
Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells. J Neurochem (2004) 1.10
RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ (2006) 1.10
Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis (2009) 1.09
Statins and neuroprotection: a prescription to move the field forward. Ann N Y Acad Sci (2010) 1.05
Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Biochem Pharmacol (2004) 1.05
Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappaB-dependent antiapoptotic gene products: role of IkappaBalpha kinase and TGF-beta-activated kinase-1. J Immunol (2007) 1.05
Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem Biophys Res Commun (1994) 1.04
Diverse effects of statins on angiogenesis: new therapeutic avenues. Pharmacotherapy (2010) 1.01
The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells. Leukemia (2002) 1.01
Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun (1994) 1.01
Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis. BMC Cancer (2012) 0.99
Stabilization and translocation of p53 to mitochondria is linked to Bax translocation to mitochondria in simvastatin-induced apoptosis. Biochem Biophys Res Commun (2009) 0.98
Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiol Dis (2006) 0.96
Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells. Eur J Pharmacol (2011) 0.96
Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer. J Biol Chem (2007) 0.94
Statins: drugs for Alzheimer's disease? J Neural Transm (Vienna) (2005) 0.92
Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating AMP-activated protein kinase. Int J Cardiol (2010) 0.91
Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells. Br J Pharmacol (2009) 0.89
Class-specific pro-apoptotic effect of statins on human vascular endothelial cells. Z Kardiol (2004) 0.89
Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin. Biochem Biophys Res Commun (1998) 0.88
Inhibitory effect of statins on the proliferation of human breast cancer cells. Int J Clin Pharmacol Ther (2004) 0.88
Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins. J Physiol Pharmacol (2007) 0.87
Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition. Mol Cell Neurosci (2001) 0.87
Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa. Thromb Res (2007) 0.85
Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease. Mol Neurobiol (2012) 0.85
In vivo cardioprotection by pitavastatin from ischemic-reperfusion injury through suppression of IKK/NF-κB and upregulation of pAkt-e-NOS. J Cardiovasc Pharmacol (2011) 0.84
Mevastatin-induced apoptosis and growth suppression in U266 myeloma cells. Anticancer Res (2004) 0.84
Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells. Mol Neurobiol (2010) 0.83
Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2. J Thromb Haemost (2008) 0.83
Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Biochem Pharmacol (2006) 0.83
Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol (2010) 0.83
Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo? Vascul Pharmacol (2010) 0.82
Effect of fluvastatin on apoptosis in human CD4+ T cells. Cell Immunol (2005) 0.81
c-Jun N-terminal protein kinase signalling pathway mediates lovastatin-induced rat brain neuroblast apoptosis. Biochim Biophys Acta (2006) 0.81
Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes. Clin Res Cardiol (2010) 0.80
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. Neurosci Lett (2008) 0.80
Pleiotropic effects of simvastatin are associated with mitigation of apoptotic component of cell death upon lethal myocardial reperfusion-induced injury. Physiol Res (2012) 0.80
Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis. Anticancer Res (2000) 0.79
Comparison of dexamethasone and lovastatin (mevinolin) as growth inhibitors in cultures of T-cell derived human acute leukemia lines (CEM). Leuk Res (1989) 0.79
Pro-apoptotic effect of fluvastatin on human smooth muscle cells. Eur J Pharmacol (1999) 0.79
Mechanisms involved in cardioprotective effects of pravastatin administered during reoxygenation in human myocardium in vitro. Anesthesiology (2012) 0.78
Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells. Kidney Int (2003) 0.77
Mechanisms of inhibitory effects of cerivastatin on rat vascular smooth muscle cell growth. J Cardiovasc Pharmacol (2002) 0.76
Simvastatin protects human osteosarcoma cells from oxidative stress-induced apoptosis through mitochondrial-mediated signaling. Mol Med Rep (2011) 0.76
Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol (2003) 1.17
Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem (2007) 1.16
Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther (2004) 1.16
Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal (2012) 1.12
Coincident enrichment of phosphorylated IkappaBalpha, activated IKK, and phosphorylated p65 in the axon initial segment of neurons. Mol Cell Neurosci (2006) 1.11
Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis (2009) 1.09
Tocotrienols: constitutional effects in aging and disease. J Nutr (2005) 1.09
Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease. Mol Neurobiol (2012) 1.07
Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem (2003) 1.06
Statins and neuroprotection: a prescription to move the field forward. Ann N Y Acad Sci (2010) 1.05
Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res (2003) 1.01
Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol Aging (2002) 0.99
Isoprenoids, small GTPases and Alzheimer's disease. Biochim Biophys Acta (2010) 0.98
Cholesterol asymmetry in synaptic plasma membranes. J Neurochem (2011) 0.96
Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiol Dis (2006) 0.96
Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. Biochim Biophys Acta (2003) 0.94
Cholesterol: Coupling between membrane microenvironment and ABC transporter activity. Biochem Biophys Res Commun (2007) 0.93
A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection. Anal Bioanal Chem (2010) 0.92
Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice. Mol Neurobiol (2012) 0.90
Effects of antidepressants on the brain/plasma distribution of corticosterone. Neuropsychopharmacology (2006) 0.90
Do tocotrienols have potential as neuroprotective dietary factors? Ageing Res Rev (2011) 0.90
Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis. J Neurochem (2014) 0.90
Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP). Anal Bioanal Chem (2008) 0.89
Enlarging the scope of cell-penetrating prenylated peptides to include farnesylated 'CAAX' box sequences and diverse cell types. Chem Biol Drug Des (2010) 0.89
Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos (2008) 0.89
Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice. Neuroreport (2002) 0.87
Mitochondria: mitochondrial membranes in brain ageing and neurodegeneration. Int J Biochem Cell Biol (2012) 0.87
Dimebon ameliorates amyloid-β induced impairments of mitochondrial form and function. J Alzheimers Dis (2012) 0.87
Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime. Mol Neurobiol (2014) 0.87
The interaction of beta-amyloid protein with cellular membranes stimulates its own production. Biochim Biophys Acta (2009) 0.86
Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria. Prostaglandins Leukot Essent Fatty Acids (2012) 0.86
Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice. Neuromolecular Med (2006) 0.85
Hydroxytyrosol-rich olive mill wastewater extract protects brain cells in vitro and ex vivo. J Agric Food Chem (2007) 0.84
Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells. Mol Neurobiol (2010) 0.83
Rice bran extract protects from mitochondrial dysfunction in guinea pig brains. Pharmacol Res (2013) 0.83
Cardiac oxidative stress and inflammation are similar in SAMP8 and SAMR1 mice and unaltered by curcumin and Ginkgo biloba extract intake. Curr Pharm Biotechnol (2010) 0.82
AP-2β regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytes. Brain Res (2012) 0.82
Cellular membrane fluidity in amyloid precursor protein processing. Mol Neurobiol (2014) 0.82
Statins and neuroprotection: basic pharmacology needed. Mol Neurobiol (2014) 0.81
Is hypercholesterolemia a risk factor for Alzheimer's disease? Mol Neurobiol (2005) 0.81
Amyloid beta enhances cytosolic phospholipase A2 level and arachidonic acid release via nitric oxide in APP-transfected PC12 cells. Acta Biochim Pol (2007) 0.80
The senescence-accelerated mouse-prone 8 is not a suitable model for the investigation of cardiac inflammation and oxidative stress and their modulation by dietary phytochemicals. Pharmacol Res (2013) 0.79
Adenosine triphosphate concentrations are higher in the brain of APOE3- compared to APOE4-targeted replacement mice and can be modulated by curcumin. Genes Nutr (2014) 0.79
Atorvastatin requires geranylgeranyl transferase-I and Rac1 activation to exert neuronal protection and induce plasticity. Neurochem Int (2013) 0.79
Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria. Mol Neurobiol (2012) 0.78
Heterologously expressed GLT-1 associates in approximately 200-nm protein-lipid islands. Biophys J (2006) 0.78
Enhanced student experience: an analysis of subjective evaluation and objective learning success after the transformation of a pharmaceutical physiology course. Adv Physiol Educ (2010) 0.78
A rapid and sensitive assay for determining human brain levels of farnesyl-(FPP) and geranylgeranylpyrophosphate (GGPP) and transferase activities using UHPLC-MS/MS. Anal Bioanal Chem (2010) 0.78
Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production. Mol Neurobiol (2010) 0.78
Laser-induced liquid bead ion desorption mass spectrometry: an approach to precisely monitor the oligomerization of the β-amyloid peptide. Anal Chem (2012) 0.78
Geranylgeranyl pyrophosphate is crucial for neuronal survival but has no special role in Purkinje cell degeneration in Niemann Pick type C1 disease. J Neurochem (2015) 0.77
Cytoprotective effects of olive mill wastewater extract and its main constituent hydroxytyrosol in PC12 cells. Pharmacol Res (2010) 0.77
Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry. Anal Chem (2003) 0.77
Rice bran extract improves mitochondrial dysfunction in brains of aged NMRI mice. Nutr Neurosci (2015) 0.76
Hypochlorous acid scavenging properties of local Mediterranean plant foods. Lipids (2004) 0.76
Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation. Mol Nutr Food Res (2007) 0.76
Evaluation of prenylated peptides for use in cellular imaging and biochemical analysis. Methods Mol Biol (2014) 0.75
Impaired geranylgeranyltransferase-I regulation reduces membrane-associated Rho protein levels in aged mouse brain. J Neurochem (2014) 0.75
Peptidomimetics That Inhibit and Partially Reverse the Aggregation of Aβ1-42. Biochemistry (2017) 0.75
Mass spectral characterization of phloroglucinol derivatives hyperforin and adhyperforin. Rapid Commun Mass Spectrom (2006) 0.75
Alzheimer's disease: new perspectives on therapeutic targets and pathways. Foreword. Mol Neurobiol (2012) 0.75
Cholesterol attenuates the membrane perturbing properties of beta-amyloid peptides. Amyloid (2002) 0.75